Publications by authors named "Miku Ito"

Claim this Profile
C
Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.
Kazuhito Suzuki, Miku Ito, Chika Sakai, Hiroaki Tsuchiya, David Bin-Chia Wu

Curr Med Res Opin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study.
Hideaki Miyake, Rikiya Matsumoto, Kiyohide Fujimoto, Atsushi Mizokami, Hirotsugu Uemura, Miku Ito

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and outcomes in a long-term registry study of patients with high-risk metastatic hormone-naïve prostate cancer in Japan: An interim analysis of the J-ROCK study.
Hirotsugu Uemura, Rikiya Matsumoto, Atsushi Mizokami, Hideaki Miyake, Hiroji Uemura, Kazutaka Saito, Miku Ito

Int J Urol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN study.
Hirotsugu Uemura, Gaku Arai, Hiroji Uemura, Hiroyoshi Suzuki, Junya Aoyama, Miku Ito

Int J Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sediment influx on the settlement and survival of canopy-forming macrophytes.
Hayato Watanabe, Miku Ito, Akira Matsumoto, Hisayuki Arakawa

Sci Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis